First experience of hepatic radioembolization using microspheres labelled with yttrium-90 (TheraSphere): practical aspects concerning its implementation
- 10 October 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 37 (3), 453-461
- https://doi.org/10.1007/s00259-009-1279-6
Abstract
We report a first experience involving the use of 90Y radiolabelled microspheres (TheraSphere) for the treatment of mainly primary hepatic tumours.Keywords
This publication has 15 references indexed in Scilit:
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Radioembolization with 90Yttrium Microspheres: A State-of-the-Art Brachytherapy Treatment for Primary and Secondary Liver Malignancies: Part 1: Technical and Methodologic ConsiderationsJournal of Vascular and Interventional Radiology, 2006
- Association of cisplatin and intra-arterial injection of 131I-lipiodol in treatment of hepatocellular carcinoma: Results of phase II trialInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Treatment of Unresectable Hepatocellular Carcinoma with Use of 90Y Microspheres (TheraSphere): Safety, Tumor Response, and SurvivalJournal of Vascular and Interventional Radiology, 2005
- Safe radiation exposure of medical personnel by using simple methods of radioprotection while administering 131I-lipiodol therapy for hepatocellular carcinomaNuclear Medicine Communications, 2003
- Yttrium-90 Microspheres: Radiation Therapy for Unresectable Liver CancerJournal of Vascular and Interventional Radiology, 2002
- Intrahepatic (90)Y-microspheres for hepatocellular carcinoma.2001
- Intraarterial HCC Therapy with I-131-LipiodolCancer Biotherapy & Radiopharmaceuticals, 2000
- A phase I dose escalation trial of yttrium-90 microspheres in the treatment of primary hepatocellular carcinomaCancer, 1992
- Hepatocellular carcinoma: pilot trial of treatment with Y-90 microspheres.Radiology, 1989